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Brainstem Auditory Evoked Responses in an Equine Patient
Population. Part II: Foals
M. Aleman, J.E. Madigan, D.C. Williams, and T.A. Holliday†
Background: Reports of the use of brainstem auditory evoked response (BAER) as a diagnostic modality in foals have
been limited.
Hypothesis/Objectives: To describe BAER findings and associated causes of hearing loss in foals.
Animals: Study group 18 foals (15 neonatal, 3 nonneonatal), control group (5 neonatal foals).
Methods: Retrospective. BAER records from the Clinical Neurophysiology Laboratory were reviewed from the years
of 1982 to 2013. Peak latencies, amplitudes, and interpeak intervals were measured when visible. Clinical data were
extracted from the medical records. Foals were grouped under disease categories. Descriptive statistics were performed.
Results: Ten neonatal foals had complete absence of BAER bilaterally and 5 had findings within reference range.
Abnormalities were associated with common neonatal disorders such as sepsis, neonatal encephalopathy, neonatal iso-
erythrolysis, and prematurity. BAER loss also was observed in foals with specific coat color patterns such as completely or
mostly white with blue irides or lavender with pale yellow irides. An American Miniature foal with marked facial deforma-
tion also lacked BAER bilaterally. One nonneonatal foal with an intracranial abscess had no detectable BAER peaks bilat-
erally, and 2 older foals, 1 with presumed equine protozoal myeloencephalitis and the other with progressive scoliosis and
ataxia, had BAER within normal limits.
Conclusions and Clinical Importance: In neonatal foals, BAER deficits commonly are complete and bilateral, and asso-
ciated with common neonatal disorders and certain coat and eye color patterns. Sepsis, hypoxia, bilirubin toxicity, and
prematurity should be investigated as potential causes of auditory loss in neonatal foals.
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Brainstem auditory evoked response (BAER) testingis an objective assessment of auditory function
and localization of lesions within the auditory path-
way.1 Postnatal BAER varies among species.1–7
Results are dependent on whether the species is preco-
cial such as chicken, sheep, cattle, and horses, or altri-
cial such as humans, monkeys, dogs, and cats.3,4,7–11
In contrast to altricious species, precocious animals are
born with fully formed brains, functional hearing, and
functional vision.10,11 Peer-reviewed publications in the
English literature about the use of BAER testing in
foals are limited to 3 studies.7,12,13 Of these reports,
only 2 include descriptions of BAER in neonatal
foals.7,12 One report described BAER performed in 4
healthy neonatal foals (48–104 hours old) and 6 neo-
natal foals (14–48 hours old) born to dams grazed on
endophyte-infected fescue.7 There were no differences
in BAER peaks, latencies, and peak V/I amplitude
ratios between healthy and fescue-exposed neonatal
foals.7 BAER reference values for neonatal foals were
provided.7 The second study investigated auditory
function in American Paint horses.12 This study
included 3 neonatal foals diagnosed with lethal white
foal syndrome (LWFS) which had absence of all peaks
on BAER testing.12 A different study reported a 2-
month-old Appaloosa colt with multifocal brainstem
disease presumed to be because of equine protozoal
myeloencephalitis.13 This colt had BAER within adult
reference range.13
Bilateral hearing loss in human neonatal intensive
care units has been reported to range from 2 to
13.4%.14–16 However, when grouped under disease
processes, hearing loss could range from 3 to 57%.15
There is a lack of information regarding alterations in
auditory function, as supported by BAER testing, and
associated causes in foals. Furthermore, the effects of
sepsis, perinatal hypoxia and marked hyperbilirubin-
emia on hearing have not been reported in neonatal
foals. Therefore, the purpose of this study was to
describe BAER findings and associated causes of hear-
ing loss in foals (neonatal and nonneonatal) presented
to a referral institution.
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Abbreviations:
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LFS lavender foal syndrome
LWFS lethal white foal syndrome
MYO myoclonus
NE neonatal encephalopathy
NI neonatal isoerythrolysis
SND sensorineural deafness
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Materials and Methods
Animals
This retrospective study included foals (neonatal and nonneona-
tal) of any breed that had BAER performed in the Clinical Neuro-
physiology Laboratory at the William R. Pritchard Veterinary
Medical Teaching Hospital from the University of California at
Davis between the years of 1982 and 2013. The BAER database
included paper (1982–1998) and electronic (1999–2013) records.
Data collected consisted of signalment, presenting complaint,
physical and neurologic examination findings, BAER results, clini-
cal or definitive diagnosis, and outcome. Data from 5 healthy neo-
natal Thoroughbred foals (3 colts, 2 fillies), 12–24 hours old were
used as controls for the neonatal group. Published values from
others also were used as reference.7 For nonneonatal foals, BAER
results from healthy adult horses were used as reference.17
Brainstem Auditory Evoked Response Testing
BAER testing was done according to laboratory protocols for
equine BAER as described elsewhere.17 Briefly, because of
the duration of the study period, different evoked potentials sys-
temsa–e were used for recording BAER. Neonatal foals were evalu-
ated in the intensive care unit and not sedated because of their
disease. Nonneonatal foals were evaluated in the stall and sedated
with xylazine hydrochloride at a dosage of 0.3–0.4 mg/kg IV.
Head phones or earphonesf were placed next to or deep into the
external ear canals, respectively. Subcutaneous needle electrodesg
were placed at the vertex (V) on midline, left mastoid, right mas-
toid, dorsal midline at the level of C2 vertebra (C2), and ground
(Z) between the occipital protuberance and C2 (Fig 1A).17 Specifi-
cations for BAER recording, and labeling of positive and negative
peaks were the same as those described elsewhere.17 Each BAER
recording was the average of a minimum of 400 responses over a
10 ms epoch. An alternating (rarefaction plus condensation)
broadband click stimulus at 90 decibels hearing level (dB HL) was
applied. Noise masking sound for the contralateral side was done
at 60 dB HL.17 All BAER studies were done in duplicates and 2
derivations for testing were used simultaneously per ear: (1) vertex
to ipsilateral mastoid (V-M); and (2) vertex to C2 (V-C2).17
Determination of normal versus abnormal BAER was based
on the following measurements: Latency and amplitude for peaks
I, III, and V measured in milliseconds (ms) and microvolts (lV),
respectively; interpeak intervals for latency among peaks I–III,
III–V, and I–V; and amplitude ratio determined by dividing peak
V by peak I on the vertex to C2 derivation.17 The recordings
were considered abnormal and consistent with hearing loss as fol-
lows: Absence of identifiable BAER peaks was most consistent
with complete hearing loss whereas increased peak latency (pro-
longed beyond 2 standard deviations [SD] from normal mean
values) and difficulty identifying peaks (decreased amplitude)
were suggestive of partial hearing loss.17–19
Statistical Analysis
Descriptive statistics (eg, mean, SD, and range) were calcu-
lated for the data obtained.
Results
Animals
Eighteen foals had BAER performed during the
study period: 15 neonatal foals and 3 nonneonatal
foals.
Neonatal Foals. Neonatal foals were Thoroughbred
(n = 4), Quarter Horse (n = 3), White Overo (n = 3),
Arabian (n = 2), and 1 each of Peruvian Paso, Welsh
pony, and American Miniature. Their ages ranged
from 12 to 96 hours old at the time of presentation.
The most common complaints were marked lethargy,
failure to nurse, weakness, and recumbency. Another
common clinical sign was seizures. All 3 white overos
were presented for apparent severe abdominal pain
and distension, and lack of defecation. The diagnostic
evaluation consisted of clinical pathology testing
(CBC, serum biochemistry, and arterial blood gas
analysis), blood culture, thoracic and abdominal ultra-
sound examination, and otoscopic examination. Eight
of 15 foals had sepsis based on a positive blood culture
(6/8 foals) or sepsis score >11 (8/8 foals).20 Microbial
organisms isolated by blood culture, or transtracheal
wash, or both included Staphylococcus sp, Klebsiella
sp, Actinobacillus sp, beta Streptococcus, Pseudomonas,
and Escherichia coli. Atlanto-occipital cerebrospinal
fluid centesis was performed in 6 of 8 foals with sepsis,
and showed lymphocytic pleocytosis with increased
protein concentration. With the exception of 2 foals in
this group, those with sepsis had other concurrent
problems.
Based on physical examination and initial diagnostic
findings, neonatal foals were grouped by disease pro-
cess as follows: LWFS (n = 3), neonatal encephalopa-
thy (NE, n = 3), failure of passive transfer and sepsis
alone (n = 2), prematurity (n = 2, 310, and 312 days
gestational age respectively), neonatal isoerythrolysis
(NI, n = 1), juvenile idiopathic epilepsy (n = 1), laven-
der foal syndrome (LFS, n = 1), myoclonus (n = 1),
and multiple congenital malformations including facial
deformation (n = 1). Of 8 foals with sepsis, 3/8 foals
also were diagnosed with NE, 2/8 foals were prema-
ture, and 1/8 was an Arabian lavender filly that never
stood up and presented with seizures (Table 1). A
4-day-old Thoroughbred colt with NI had a packed
cell volume of 9% (reference range, 33.4–45%), serum
total bilirubin concentration of 31.8 mg/dL (reference
range, 1–3 mg/dL), indirect bilirubin concentration of
23.3 mg/dL (reference range, 0.6–2.6 mg/dL), direct
bilirubin concentration of 8.5 mg/dL (reference range,
0.3–0.7 mg/dL), plasma lactate concentration of
8.22 mmol/L (reference range, 1–2 mmol/L), and SpO2
in the range of 85–92% (reference range, 98–100%) on
presentation. This foal was obtunded, dysphagic (lip
and tongue incoordination), and had seizures. An elec-
troencephalogram disclosed the presence of epilepti-
form discharges. The foal was discharged after 20 days
of intensive care but remained dysphagic (nasogastric
tube in place) and presented again 11 days later with
profuse diarrhea and emaciation. The foal died from
sepsis and typhlocolitis caused by Salmonella typhimu-
rium. Outcome at discharge for all foals is shown in
Table 1.
Nonneonatal Foals. Nonneonatal foals consisted of 3
foals: a 2-month-old Appaloosa colt presented with pro-
gressive multifocal brainstem disease and a presumptive
diagnosis of equine protozoal myeloencephalitis caused
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by Sarcocystis neurona based on Western blot serology
testing (the only test available at the time) and favorable
response to treatment; a 7-month-old Quarter Horse
filly presented for chronic progressive severe scoliosis,
ataxia, and possible deafness; and, a 3-month-old Quar-
ter Horse colt with an intracranial extra-axial abscess
compressing the brainstem (Table 1). Outcome is shown
on Table 1.
Brainstem Auditory Evoked Response Testing
Neonatal Foals. BAER testing was performed within
hours to a few days after presentation. Ten neonatal
foals had bilaterally absent BAER as follows: LWFS
3/3, NE 2/3, premature 2/2, NI 1/1, LFS 1/1, and 1
American Miniature foal with multiple congenital mal-
formations (Table 1). None of the neonatal foals had
unilateral BAER abnormalities, and 5 foals had BAER
results within reference range (Table 2; Fig 1B). BAER
data from diseased neonatal foals are not provided
either because of absent BAER or peaks that were un-
identifiable as shown in Figure 1C,D.
Nonneonatal Foals. Two foals had BAER within
published reference ranges for adults,17 and the colt
with an intracranial abscess had no detectable BAER
peaks bilaterally (Table 1).
Discussion
Hearing deficits occur in foals as identified in this
study. Furthermore, complete absence of BAER was
identified in neonatal foals with common neonatal dis-
orders such as sepsis, NE caused by hypoxia, prematu-
rity, and NI. Congenital or hereditary disorders such
as multiple malformations and particular coat color
patterns can be associated with auditory function
impairment. Results of this study also emphasize the
importance of performing a comprehensive neurologic
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Fig 1. (A) BAER electrode placement. Derivations used: vertex to mastoid (left, right) and vertex to C2. V, vertex; RM, right mastoid;
LM, left mastoid; C2, level of second cervical vertebra; Z, ground. Ear phones not shown. (B) BAER from a healthy neonatal foal.
Study done in duplicates (shown), 2 derivations are shown (V-M, V-C2), top 2 tracings correspond to left ear stimulation, bottom 2 trac-
ings correspond to right ear stimulation. Note peaks are labeled. (C) BAER from a neonatal foal with neonatal isoerythrolysis. Two der-
ivations are shown, top 2 = left ear, bottom 2 = right ear. Note accurate identification of BAER peaks was not possible. (D) BAER
from a neonatal foal with lethal white foal syndrome. Two derivations are shown, top 2 = left ear, bottom 2 = right ear. Note absent
BAER bilaterally. Only one data set displayed.
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examination in foals, particularly in neonatal foals pre-
senting to the intensive care unit because many neona-
tal disorders have similar signs.21 Alterations in
behavior and states of consciousness, absent or weak
suckle reflex, weakness, and recumbency are common
clinical signs.21 Assessing the level of hearing based on
behavioral response would likely be difficult in criti-
cally ill neonatal foals because of the state of their dis-
ease. Furthermore, the effects of sepsis, hypoxia, or
marked hyperbilirubinemia on hearing have not been
described or evaluated in foals. As the first step in the
investigation of hearing loss by BAER studies, refer-
ence ranges must be established in healthy animals
according to age, technique, and derivation used.1,22
Other important considerations include breed and sex,
which were not evaluated in this study because of the
low numbers of foals.23
This study also provided reference values for BAER
testing in neonatal foals using 2 different derivations:
vertex to mastoid and vertex to C2. There is a single
BAER study in which reference values from 4 neonatal
foals were reported using the vertex to mastoid deriva-
tion.7 In addition, BAER thresholds were investigated
from 10 to 90 dB sound pressure level (SPL).7 Distinct
peaks (I–III, V) were seen in 4 healthy and all 6 fes-
cue-exposed neonatal foals at stimulus intensities of 70
and 90 dB SPL.7 Peaks also were visible at 50 dB SPL
in some foals, and, at lower stimuli, the majority of
foals did not have identifiable peaks.7 When tested at
stimulus levels of 90 dB SPL, most of the BAER laten-
cies in foals were within 3 SD of the reported values
for adult horses tested at the same stimulus intensi-
ties.7 Therefore, the authors concluded that peak laten-
cies in neonatal foals can be compared to those of
adult horses.7,24,25 Our findings concur with these
observations. However, BAER thresholds might be
necessary to detect more subtle alterations in auditory
function.
Eight of 15 neonatal foals had sepsis. Of these, 6
foals had other concurrent problems which included
Table 1. Hearing loss in foals: neonates (top table), nonneonatal foals (bottom table). Note hearing loss in foals
by disease group (bilateral versus unilateral). Column on the right shows number of foals with normal hearing.
Neonatal Foals
(N = 15) Disease Breed Neurologic Signs (N = 15)
Bilateral (N = 10)
BAER
Unilateral
(N = 0)
BAER
Normal
(N = 5)
BAER Outcome
LWFS (N = 3) White Overo Ileus Absent BAER (3) 0 0 EU (3)
NE (N = 3) TB, QH,
Welsh Pony
Obtundation to stupor,
seizures, nystagmus,
recumbency
Difficult to distinguish (2) 0 1 EU (2)
S (1)
FPT/Sepsis (N = 2) TB, QH Obtundation, apparent
weakness
0 0 2 S (2)
Premature (N = 2) TB, QH Stupor, seizures, nystagmus Difficult to distinguish (2) 0 0 EU (2)
NI (N = 1) TB Obtundation, seizures,
dysphagia
Difficult to distinguish 0 0 DIED (1)
JIE (N = 1) Arabian Seizures 0 0 1 S (1)
LFS (N = 1) Arabian Opisthotonus, nystagmus,
seizures, tremors, stiffness,
inability to stand
Absent BAER 0 0 EU (1)
MYO (N = 1) Peruvian Paso Recumbency, tremors,
myoclonus
0 0 1 EU (1)
CM (N = 1) Am Miniature Obtundation, stiffness,
dysmetria
Difficult to distinguish 0 0 EU (1)
Total (N = 15) 15 10 0 5 EU (11)
S (4)
Nonneonatal Foals
(N = 3) Disease Signalment Neurologic Signs (N = 3)
Bilateral
(N = 1)
BAER
Unilateral
(N = 0)
BAER
Normal
(N = 2)
BAER Outcome
EPM suspect (N = 1) 2 m Appaloosa Colt Obtundation, multiple
cranial nerves deficits
NA NA 1 S
Brain Abscess (N = 1) 3 m QH Colt Stupor, seizures, multiple
cranial nerves deficits
1 NA NA EU
Scoliosis (N = 1) 7 m QH Filly Ataxia, asymmetrical
tetraparesis, dysmetria,
muscle atrophy
NA NA 1 EU
Total (N = 3) 3 1 0 2 EU (2)
S (1)
LWFS, lethal white foal syndrome; NE, neonatal encephalopathy; FPT, failure of passive transfer; NI, neonatal isoerythrolysis; JIE,
juvenile idiopathic epilepsy; LFS, lavender foal syndrome; MYO, myoclonus of Peruvian Paso; CM, congenital malformations; difficult
to distinguish, difficult to distinguish BAER peaks; S, survived; EU, euthanasia; m, age in months; NA, not applicable.
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NE because of hypoxic ischemia (n = 3), prematurity
(n = 2), and LFS (n = 1). Cerebrospinal fluid cytology
showed inflammation in 6 foals but was not consistent
with septic meningitis. However, sampling at early
stages of disease might play a role in cytologic find-
ings.26 Sepsis and meningitis have been reported to be
causes of hearing loss in newborn infants.15,16 In a
review of neurodevelopmental dysfunction in newborn
infants, hearing loss was detected in 10 and 12% of
newborns with sepsis and meningitis, respectively.15,16
Two neonatal foals diagnosed with sepsis alone had
BAER within reference ranges. Five of 6 foals with
sepsis and other concurrent problems had no identifi-
able BAER bilaterally.
Two of 3 foals with NE that suffered from hypoxic
ischemia in the perinatal period had no identifiable
BAER. The remaining foal had normal BAER. Neuro-
logic disabilities after intrapartum hypoxic ischemia in
newborn infants include cerebral palsy, learning and
memory disabilities, epilepsy, attention disorders, and
visual and hearing impairment.27 Some neonatologists
believe that hypoxia damages the hair cells of the
cochlea,14 others have reported that the prevalence of
hearing impairment in newborn infants with NE
because of hypoxia is not substantially higher than in
those without NE.28 However, results from a recent
review of 27 studies reported hearing loss in 9%
(n = 291/2,708) of newborn infants with hypoxic ische-
mic encephalopathy.15 Because of severity of disease
and lack of response to intensive care, 2 foals were
euthanized. The third foal with normal BAER findings
was discharged from the hospital.
Two premature foals in this study were found to
have absent BAER bilaterally. However, these foals
also were septic, and whether prematurity or sepsis
was the cause of hearing loss was unknown. It is also
unknown at what stage of maturation in utero the
auditory system becomes fully functional in foals.
Birth weight in newborn infants is an indicator of bio-
logic maturity.29 Two of 3 infants with low birth
weight are premature.29 Extremely premature babies
(<32 weeks of gestation) or infants with very low birth
weight (<1,500 g) regardless of gestational age are
considered a population at higher risk for sensorineu-
ral hearing loss.29 The prevalence of childhood sensori-
neural hearing loss among premature newborn infants
from several studies was 7%.15
A 4-day-old Thoroughbred colt with NI and marked
hyperbilirubinemia (31.8 mg/dL) had unidentifiable
BAER peaks in both ears. Bilirubin encephalopathy,
more commonly known as kernicterus, is an important
cause of neurologic dysfunction and permanent brain
damage in newborn infants.30 In a study of 72 foals
with NI, 18 foals did not survive.31 Of these, 9 foals
had severe neurologic signs (2 died, 7 euthanized).31
Histologic evaluation of the brain was consistent with
kernicterus and hepatic encephalopathy in 6 and 1
neonatal foals, respectively, and no lesions were
observed in 2 foals.31 None of the survivors displayed
neurologic signs.31 The globus pallidus, subthalamic
nucleus, auditory pathway, and oculomotor brainstem
nuclei are most vulnerable to bilirubin toxicity in new-
born infants.30 Other areas affected by bilirubin
include the cerebellar Purkinje cell layer and hippo-
campus.30 The affected areas in foals with NI comprise
the cerebral cortex, hippocampus, and cerebellar Pur-
kinje layer.31 In the foal in our study, no histologic
lesions were identified in the brain. However, the pre-
cise sites of histologic evaluation were not specified in
the report. Therefore, inappropriate selection of sam-
ples could have resulted in failure to identify lesions.
Foals with kernicterus had reported total serum biliru-
bin concentrations that ranged from 19 to 41 mg/dL.31
Furthermore, the authors concluded that foals with
total bilirubin concentrations ≥27 mg/dL were 17 times
more likely to develop kernicterus than foals with
lower concentrations.31 In newborn infants with biliru-
bin encephalopathy, motor, auditory, and cognitive
dysfunction are the most common permanent abnor-
malities.30 In the acute stages, lethargy, ophthalmople-
gia, high pitched vocalization, opisthotonus, and
seizures are the most common signs of kernicterus.30
Although neurologic signs vary depending on whether
bilirubin toxicity is acute or chronic, one of the cardi-
nal signs is auditory impairment, which can range
from subtle to complete lack of hearing.30,32 This study
reports for the first time auditory dysfunction in a colt
with marked hyperbilirubinemia. However, hypoxia
Table 2. BAER reference values for neonatal foals recorded after stimulating at 90 dB HL with head phones.
Neonates
Latency (ms) Amp (lV)
I III V I–III III–V I–V V/I
V-M
Controls (N = 5)
90 dB HL
1.36 (0.05) 2.31 (0.36) 4.41 (0.09) 0.95 (0.26) 2.10 (0.25) 3.06 (0.07) NA
Steiss 1991 (N = 4)
90 dB SPL
1.44 (0.05) 3.77 (0.26) 4.64 (0.17) NA NA NA 0.56 (0.21)
V-C2
Controls (N = 5)
90 dB HL
1.2 (0.05) 2.19 (0.26) 4.56 (0.18) 0.98 (0.24) 2.53 (0.54) 3.36 (0.13) 3.31 (1.2)
Note reference values were obtained using different measurements of sound level (HL versus SPL).
Controls, UCD healthy foals; Steiss 1991, Study by Steiss in neonatal foals using 90 dB SPL (reference values not available for the
V-C2 derivation)7; NA, not available or not applicable.
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(because of profound anemia) may also have been a
factor. In addition to BAER abnormalities in this colt,
other signs such as obtundation, seizures, and dyspha-
gia (because of incoordination of lips and tongue)
could be attributed to bilirubin toxicity.30 The basal
nuclei, which include the globus pallidus, affect motor
activity of the lips and tongue, functions that this colt
did not regain.33
Hereditary and congenital disorders in this study
comprised 3 neonatal foals with LWFS, 1 Arabian filly
with LFS, and 1 American Miniature colt with multi-
ple congenital malformations including a facial defor-
mation that occluded the internal and external
acoustic meatus. Hereditary and congenital disorders
have been reported to be a major cause of comorbidi-
ties in newborn infants.16 These comorbidities include
hearing loss.16 Congenital sensorineural deafness asso-
ciated with a genetic mutation in the endothelin B
receptor (EDNBR) gene was identified in 3 white overo
neonatal foals in this study.12,34,35 This receptor plays
an essential role in neural crest development.34–36 Mel-
anocytes are derived from the neural crest and migrate
to the skin and inner ear.36 Therefore, alterations in
this receptor can result in pigmentation and hearing
impairment.35 Horses with certain color patterns can
be carriers of the mutation, such as paints with exten-
sive white areas and white faces and heterochromic or
blue irides.12 The foal with LFS also was septic, and
whether absence of BAER was associated with the
coat color dilution, sepsis, or both was unclear. How-
ever, hearing loss has not been reported in foals with
LFS, but warrants investigation.37 The disorder is
caused by a myosin 5A (MYO5A) genetic mutation
with an autosomal recessive mode of inheritance in
Egyptian Arabian horses.38 Affected foals are homozy-
gous for the mutation.38 MYO5A gene mutation
results in a frame shift and premature termination of
transcription of the secretory vesicle-specific binding
domain of the protein involved in vesicle traffic.38 This
loss of vesicle traffic can interfere with the normal
function of melanocytes and neurons.38
In conclusion, foals are born with a functional audi-
tory system comparable to that of adult horses when
tested at 90 dB HL. Brain insults in the perinatal per-
iod such as those associated with sepsis, hypoxic ische-
mia, and marked hyperbilirubinemia should be
considered as potential causes of hearing loss in neona-
tal foals. Prematurity could result in a nonfunctional
auditory system similar to that reported in premature
infants.16 Furthermore, neonatal foals are commonly
presented with a combination of problems possibly
increasing the risk of hearing impairment. Congenital
or inherited disorders such as those associated with
multiple malformations and coat color patterns also
should be considered as potential associations with
hearing loss. Subjective evaluation and interpretation
of hearing in the critically ill neonatal foal can be diffi-
cult and inaccurate. BAER testing should be consid-
ered in patients with suspected neurologic disease,
especially if signs localize to the brain (ie, multifocal
brainstem disease), vestibular system (peripheral or
central), ear (outer, middle, or inner), or some combi-
nation of these. Similar to adult horses, BAER also is
indicated in foals with altered behavior, such as being
easily startled, particularly if these signs occur in com-
bination with certain coat and eye color patterns. As
reported horses and other species, potentially ototoxic
drugs can result in hearing impairment and should be
avoided or used cautiously in foals.16,39 BAER is a
noninvasive and objective diagnostic technique to
assess hearing in foals with neurologic disease and sus-
pected hearing deficits. Prospective studies to investi-
gate auditory function in diseased foals, especially
neonates, are needed. Such studies will aid in the
understanding of disease processes, provide useful
information to the owners with regard to special train-
ing needs and precautions because of auditory impair-
ment, and help owners make financial decisions.
Footnotes
a DANTEC Electronics; Inc, Allendale, NJ
b TecaEP40/ST10; Teca Corp, Pleasantville, NY
c Nihon Kohden Neuropack; Neuro Medical Equipment, Inc,
Arlington, TX
d Viking IVD; Nicolet Biomedical Inc, Madison, WI
e VikingQuest; Nicolet Biomedical Inc
f TIP 300; Nicolet Biomedical, Inc
g FE-2; Grass/Astro-Med Inc, West Warwick, RI
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